CN102631404B - Traditional Chinese medicine composition for treating chest impediment - Google Patents
Traditional Chinese medicine composition for treating chest impediment Download PDFInfo
- Publication number
- CN102631404B CN102631404B CN 201210142858 CN201210142858A CN102631404B CN 102631404 B CN102631404 B CN 102631404B CN 201210142858 CN201210142858 CN 201210142858 CN 201210142858 A CN201210142858 A CN 201210142858A CN 102631404 B CN102631404 B CN 102631404B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- traditional chinese
- treatment
- chest impediment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating chest impediment. The traditional Chinese medicine composition is an agentia prepared from the following bulk pharmaceutical chemicals in parts by weight: 1-10 of Cynanchum auriculatum Royle, 1-5 of Pogostemon cablin and 1-5 of Rhizoma Atractylodis. The traditional Chinese medicine composition can be prepared into medicinal tea which can be conveniently used, and has a marvelous curative effect and no side-effects when being used in such as clinical acupuncture syncope, shock, and eruptive disease, dizzy and nausea in hot summer days and the like.
Description
Technical field
The present invention relates to tcm field, relate in particular to a kind of Chinese medicine composition for the treatment of the thoracic obstruction.
Background technology
The title of the thoracic obstruction, head sees classical Chinese medicine " interior warp "." this Tibetan of Ling Shu Miraculous Pivot or Divine Axis ": " lung is polydipsia greatly then, the kind sick thoracic obstruction, sore throat, contrary gas." with pathogenic fluid-retention numbness resistance in the heart as the main pathogenesis of the thoracic obstruction.
The thoracic obstruction refers to suffocating pain over the chest, chest pain radiating to the back very then, and the failing to sleep due to dyspnea of breathing hard is a kind of disease of primary symptom.Many and the inward invasion of pathogenic cold of its cause of disease, improper diet, the fluctuation of feelings will, aged debilities etc. are relevant.The precordialgia that causes with diseases such as the coronary atherosclerotic heart disease of doctor trained in Western medicine, angina pectoris, pericarditiss respectively, and pulmonary disease, pleuritis, intercostal neuralgia etc. are that the disease of primary symptom is similar with the chest pain, the thoracic obstruction is as continuing outbreak, sharp ache, the also variable life critical syndromes such as card, the depletion syndrome of fainting.
Therefore, it is imperative to seek a kind of simple and effective Chinese medicine method treatment thoracic obstruction.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of the thoracic obstruction.
In order to realize purpose of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of the thoracic obstruction, it is the medicament of being made by weight by following bulk drugs: Caulis et Folium Cynanchi Auriculati 1-10 part, Herba Pogostemonis 1-5 part and Rhizoma Atractylodis 1-5 part.
Preferably, the Chinese medicine composition of the treatment thoracic obstruction of the present invention is the medicament of being made by weight by following bulk drugs: 3 parts of 6 parts of Caulis et Folium Cynanchi Auriculati, 3 parts of Herba Pogostemoniss and Rhizoma Atractylodis.
More preferably, described medicament is tablet, capsule, soft capsule, pill, granule, drop pill or medicinal tea.
The Chinese medicine composition of the treatment thoracic obstruction of the present invention can be made medicinal tea and use with convenient, faints in clinical acupuncture, shock and big hot summer days eruptive disease, dizziness, feels sick etc. and to use, and all has marvellous curative effect and has no side effect.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The use of embodiment 1 medicinal tea of the present invention
Get Caulis et Folium Cynanchi Auriculati 600 grams, Herba Pogostemonis 300 grams and Rhizoma Atractylodis 300 grams, pulverize, cross 80 mesh sieves, mix homogeneously.Divide and install in 100 bags.During use bag ducked in drink to drink and get final product.
Experimental example
Diagnostic criteria
" traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (ZY/T001.1~001.9-94, traditional Chinese medical science disease diagnosis criterion of therapeutical effect [S]) with reference to Ministry of Public Health promulgation in 1994 formulated.Disease is seen that ambition is close or is pressed as thing, dyspnea with shortness of breath, and gastral cavity painful abdominal mass limb is heavy, the sticking or sputum-rich yellow-thick of abundant expectoration mouth, vexed xerostomia, red tongue, yellow and greasy fur, slippery and rapid pulse.
Choose and meet above-mentioned diagnostic criteria and voluntary curer 50 examples, each 25 example of men and women wherein, the age is between 38-65 year.All patients all are diagnosed as coronary heart disease through electrocardiogram etc.
Use the tea bag of preparation among the embodiment 1 to treat, steep one bag every day, drinking 5 days continuously is a course for the treatment of, treats 3 courses for the treatment of.
Curative effect judging standard
Formulate with reference to thoracic obstruction criterion of therapeutical effect in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (ZY/T001.1~001.9-94, traditional Chinese medical science disease diagnosis criterion of therapeutical effect [S]) of Ministry of Public Health promulgation in 1994.Cure: transference cure, electrocardiogram and relevant lab testing recover normal; Take a turn for the better: sx, attack times reduces, and the intermittent time prolongs, and lab testing has improvement; Invalid: cardinal symptom and electrocardiogram do not have improvement.
Through the treatment of 3 courses for the treatment of, whole 50 routine patients all reach criterion of cure, and do not find tangible untoward reaction in therapeutic process.
Claims (2)
1. a Chinese medicine composition for the treatment of the thoracic obstruction is characterized in that, it is the medicament of being made by weight by following bulk drugs: Caulis et Folium Cynanchi Auriculati 1-10 part, Herba Pogostemonis 1-5 part and Rhizoma Atractylodis 1-5 part.
2. the Chinese medicine composition of the treatment thoracic obstruction according to claim 1 is characterized in that, it is the medicament of being made by weight by following bulk drugs: 3 parts of 6 parts of Caulis et Folium Cynanchi Auriculati, 3 parts of Herba Pogostemoniss and Rhizoma Atractylodis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210142858 CN102631404B (en) | 2012-05-10 | 2012-05-10 | Traditional Chinese medicine composition for treating chest impediment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210142858 CN102631404B (en) | 2012-05-10 | 2012-05-10 | Traditional Chinese medicine composition for treating chest impediment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102631404A CN102631404A (en) | 2012-08-15 |
CN102631404B true CN102631404B (en) | 2013-07-10 |
Family
ID=46616083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210142858 Expired - Fee Related CN102631404B (en) | 2012-05-10 | 2012-05-10 | Traditional Chinese medicine composition for treating chest impediment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102631404B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002836A (en) * | 2007-01-23 | 2007-07-25 | 贵州师范大学 | Use of the extractive of radix cynanchi bungei total glucoside |
-
2012
- 2012-05-10 CN CN 201210142858 patent/CN102631404B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101002836A (en) * | 2007-01-23 | 2007-07-25 | 贵州师范大学 | Use of the extractive of radix cynanchi bungei total glucoside |
Non-Patent Citations (5)
Title |
---|
张晓榕,等.白首乌总甾体酯苷对心脏和肝脏氧能量代谢的实验研究.《中国医药学报》.1987,第2卷(第5期),23-25. * |
王勇.痰湿与心系疾患的关系.《中医杂志》.2011,第52卷(第S1期),15-17. |
痰湿与心系疾患的关系;王勇;《中医杂志》;20111231;第52卷(第S1期);15-17 * |
等.藿香正气滴心丸的制备工艺研究.《中国药业》.2011,第20卷(第3期),28-30. * |
谢予朋 * |
Also Published As
Publication number | Publication date |
---|---|
CN102631404A (en) | 2012-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101530579B (en) | A pharmaceutical composition for soothing the nerves | |
CN104225403A (en) | Pharmaceutical composition for treating phthisis as well as preparation method and application thereof | |
CN102178892B (en) | Chinese medicinal composition for treating depression | |
CN102861199A (en) | Traditional Chinese medicine composition for treating gastroesophageal reflux disease and preparation method | |
CN102631404B (en) | Traditional Chinese medicine composition for treating chest impediment | |
CN104258023B (en) | Traditional Chinese medicine composition for treating depressive disorder | |
CN102600336A (en) | Medicament for treating asthma | |
CN102698065B (en) | Medicine composition for treating primary dysmenorrhea | |
CN101396448A (en) | Prescription for treating cervical vertebra disease | |
WO2016127771A1 (en) | Application of 20(r)-ginsenoside rg3 in preparing drug or healthcare product for alleviating or/and treating rheumatoid disease and drug containing 20(r)-ginsenoside rg3 | |
CN102178759A (en) | Traditional Chinese medicine composition for treating rheumatism and preparation method of composition | |
CN101264197B (en) | Medicine for treating sciatica | |
CN104491591A (en) | Health-care tea used for depression | |
CN103705780A (en) | Medicament for treating intractable insomnia | |
CN102670740A (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
CN102488797B (en) | Medicinal composition for treating dysmenorrhea | |
CN103520458B (en) | Pharmaceutical composition for calming the nerves on a kind of psychiatric nursing | |
CN103550519B (en) | A kind of preparation method for the treatment of the medicament of dysmenorrhea | |
CN102205049B (en) | Medicinal composition for treating premature beat | |
CN105232991A (en) | Medicine composition for treating gastric mucosal lesion | |
CN104857304B (en) | A kind of compositions purposes in the medicine of preparation treatment ascariasis of biliary tract | |
CN104383247A (en) | Traditional Chinese medicine for treating phthisis | |
CN102552581B (en) | Medicament for treating insomnia | |
CN104138413A (en) | Pharmaceutical composition for treating infantile influenza | |
CN103599503A (en) | Medicine for treating critical diseases and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130710 Termination date: 20150510 |
|
EXPY | Termination of patent right or utility model |